What is Regenxbio's net interest and investment income (loss)?

Regenxbio (RGNX) reported net interest and investment income (loss) of $2M in Q1 2026.

How has Regenxbio's net interest and investment income (loss) changed year-over-year?

Regenxbio's net interest and investment income (loss) decreased by 19.9% year-over-year, from $2.5M to $2M.

What is the long-term trend for Regenxbio's net interest and investment income (loss)?

Over 4 years (2021 to 2025), Regenxbio's net interest and investment income (loss) has grown at a 15.7% compound annual growth rate (CAGR), from $6.83M to $12.25M.

Regenxbio RGNX Net interest and investment income (loss)

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's net interest and investment income (loss).

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's net interest and investment income (loss)?: Regenxbio (RGNX) reported net interest and investment income (loss) of $2M in Q1 2026.
How has Regenxbio's net interest and investment income (loss) changed year-over-year?: Regenxbio's net interest and investment income (loss) decreased by 19.9% year-over-year, from $2.5M to $2M.
What is the long-term trend for Regenxbio's net interest and investment income (loss)?: Over 4 years (2021 to 2025), Regenxbio's net interest and investment income (loss) has grown at a 15.7% compound annual growth rate (CAGR), from $6.83M to $12.25M.